<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9873504</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">36510701</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9873504</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1111/cns.14048</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">CNS14048</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="other">CNSNT-2022-254.R1</article-id></all-ids><extracted-table><table-id>cns14048-tbl-0001</table-id><table-label>TABLE 1</table-label><table-caption>Clinical and demographic characteristics in patient with SHE and healthy control subjects.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="cns14048-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Clinical and demographic characteristics in patient with SHE and healthy control subjects.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">SHE</th><th align="left" valign="bottom" rowspan="1" colspan="1">HC</th><th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Number</td><td align="left" valign="top" rowspan="1" colspan="1">54</td><td align="left" valign="top" rowspan="1" colspan="1">50</td><td align="left" valign="top" rowspan="1" colspan="1">–</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="left" valign="top" rowspan="1" colspan="1">29.56 ± 9.22</td><td align="left" valign="top" rowspan="1" colspan="1">28.88 ± 8.91</td><td align="left" valign="top" rowspan="1" colspan="1">0.71</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender (male/female)</td><td align="left" valign="top" rowspan="1" colspan="1">34/20</td><td align="left" valign="top" rowspan="1" colspan="1">26/24</td><td align="left" valign="top" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Duration (years)</td><td align="left" valign="top" rowspan="1" colspan="1">8.49 ± 8.68</td><td align="left" valign="top" rowspan="1" colspan="1">–</td><td align="left" valign="top" rowspan="1" colspan="1">–</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Antiepileptic therapy (+/−)</td><td align="left" valign="top" rowspan="1" colspan="1">42/12</td><td align="left" valign="top" rowspan="1" colspan="1">–</td><td align="left" valign="top" rowspan="1" colspan="1">–</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Single drug/multiple drugs</td><td align="left" valign="top" rowspan="1" colspan="1">24/18</td><td align="left" valign="top" rowspan="1" colspan="1">–</td><td align="left" valign="top" rowspan="1" colspan="1">–</td></tr></tbody></table><table-wrap-foot id="cns14048-ntgp-0002"><fn id="cns14048-note-0002"><p>Abbreviations: HC, healthy control; SHE, sleep‐related hypermotor epilepsy.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Clinical and demographic characteristics in patient with SHE and healthy control subjects.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="left"/><col align="left"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom"/><th align="left" valign="bottom">SHE</th><th align="left" valign="bottom">HC</th><th align="left" valign="bottom">p</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top">Number</td><td align="left" valign="top">54</td><td align="left" valign="top">50</td><td align="left" valign="top">–</td></tr><tr><td align="left" valign="top">Age (years)</td><td align="left" valign="top">29.56 ± 9.22</td><td align="left" valign="top">28.88 ± 8.91</td><td align="left" valign="top">0.71</td></tr><tr><td align="left" valign="top">Gender (male/female)</td><td align="left" valign="top">34/20</td><td align="left" valign="top">26/24</td><td align="left" valign="top">0.26</td></tr><tr><td align="left" valign="top">Duration (years)</td><td align="left" valign="top">8.49 ± 8.68</td><td align="left" valign="top">–</td><td align="left" valign="top">–</td></tr><tr><td align="left" valign="top">Antiepileptic therapy (+/−)</td><td align="left" valign="top">42/12</td><td align="left" valign="top">–</td><td align="left" valign="top">–</td></tr><tr><td align="left" valign="top">Single drug/multiple drugs</td><td align="left" valign="top">24/18</td><td align="left" valign="top">–</td><td align="left" valign="top">–</td></tr></tbody></table></div>Abbreviations: HC, healthy control; SHE, sleep‐related hypermotor epilepsy.</transformed-table></extracted-table></extracted-tables-set>